Stay updated on Amivantamab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Amivantamab in Gastric Cancer Clinical Trial page.

Latest updates to the Amivantamab in Gastric Cancer Clinical Trial page
- Check3 days agoChange DetectedThe page footer updates the ClinicalTrials.gov release “Revision” number from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check11 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check40 days agoChange DetectedRevision metadata updated: added Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%

- Check75 days agoChange DetectedA new site revision label 'Revision: v3.4.2' was added. The old funding-status notice and the previous revision label 'Revision: v3.4.1' were removed.SummaryDifference0.4%

- Check82 days agoChange DetectedAdded a site-wide banner about the government funding lapse and NIH Clinical Center status, and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Amivantamab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab in Gastric Cancer Clinical Trial page.